Mass spectrometry as a tool for biomarkers searching in gynecological oncology

被引：21

作者：

Banach, Paulina ^{[1
]}

Suchy, Wiktor ^{[1
]}

Derezinski, Pawel ^{[2
]}

Matysiak, Jan ^{[2
]}

Kokot, Zenon J. ^{[2
]}

Nowak-Markwitz, Ewa ^{[1
]}

机构：

[1] Poznan Univ Med Sci, Div Gynecol Oncol, Dept Gynecol Obstet & Gynecol Oncol, Polna 33, PL-60535 Poznan, Poland

[2] Poznan Univ Med Sci, Dept Inorgan & Analyt Chem, Grunwaldzka 6, PL-60780 Poznan, Poland

来源：

BIOMEDICINE & PHARMACOTHERAPY | 2017年 / 92卷

关键词：

Mass spectrometry; Proteomics; Ovarian cancer; Endometrial cancer; Cervical cancer; Vulvar cancer; Breast cancer; Gestational trophoblastic disease; OVARIAN-CANCER IDENTIFICATION; DATA-INDEPENDENT ACQUISITION; BREAST-CANCER; PROTEIN EXPRESSION; PROTEOMIC ANALYSIS; REVEALS; VULVAR; SERUM; CARCINOMA; DIAGNOSIS;

D O I：

10.1016/j.biopha.2017.05.146

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Tumors of the female reproductive tract are an important target for the development of diagnostic, prognostic and therapeutic strategies. Recent research has turned to proteomics based on mass spectrometry techniques, to achieve more effective diagnostic results. Mass spectrometry (MS) enables identification and quantification of multiple molecules simultaneously in a single experiment according to mass to charge ratio (m/z). Several proteomic strategies may be applied to establish the function of a particular protein/peptide or to identify a novel disease and specific biomarkers related to it. Therefore, MS could facilitate treatment in patients with tumors by helping researchers discover new biomarkers and narrowly targeted drugs. This review presents a comprehensive discussion of mass spectrometry as a tool for biomarkers searching that may lead to the discovery of easily available diagnostic tests in gynecological oncology with emphasis on clinical proteomics over the past decade. The article provides an insight into different MS based proteomic approaches. (C) 2017 Elsevier Masson SAS. All rights reserved.

引用

页码：836 / 842

页数：7

共 73 条

[1] Annexin-A2 as predictor biomarker of recurrent disease in endometrial cancer [J].